Free 15% Customization On All Syndicated Reports.

Global Animal Antibiotics and Antimicrobials Market – Industry Analysis and Forecast (2017-2024) _ by Product (Tetracyclines, Penicillins, Sulfonamides, Macrolides and Others), by Mode of Delivery (Premixes, Oral Powders, Oral Solutions, Injections and Other Modes of Delivery), by Type of Animal (Food-Producing Animals and Companion Animals), and by Geography

Market Scenario

Global Animal Antibiotics and Antimicrobials Market is expected to reach USD 5.46 Billion by 2024 from USD 3.78 Billion in 2016 at CAGR of 4.72% (Detailed analysis of the market CAGR is provided in the report). Global Animal Antibiotics and Antimicrobaials Market Various factors driving the Animal Antibiotics and Antimicrobials market are increasing demand for animal-derived food products, rising trend of ownership of pet animals, rising demand for animal protein products, increasing incidences of zoonotic diseases, and increasing doption of Western eating habits across distant parts of the globe. Global Animal Antibiotics and Antimicrobials Market is segmented by product, mode of delivery, type of animal, and geography. Product segment is sub segmented as tetracyclines, penicillins, sulfonamides, macrolides, aminoglycosides, lincosamides, fluoroquinolones, cephalosporins and other antimicrobials and antibiotics. Mode of delivery segment is classified as premixes, oral powders, oral solutions, injections and other modes of delivery. Type of Animal segment is bifurcated as food-producing animals and companion animals. The market on the basis of geography is segmented by North America, Europe, Asia-Pacific, Middle East & Africa and Latin America. Increasing animal population and rising demand for animal-derived food products are trending the overall Global Animal Antibiotics and Antimicrobials Market. However, growing resistance to antimicrobials and antibiotics will restrain the market growth. North America is expected to dominate the Animal Antibiotics and Antimicrobials Market in forecast period followed by Europe and APAC. Increasing companion animal healthcare expenditure, growing number of food-producing animals in this region will fuel the Animal Antibiotics and Antimicrobials Market in North America region. Key Highlights: • Assessment of market definition along with the identification of key players and analysis of their strategies to determine the competitive outlook of the market, opportunities, drivers, restraints and challenges for this market during the forecast period • Complete quantitative analysis of the industry from 2016 to 2024 to enable the stakeholders to capitalize on the prevailing market opportunities • In-depth analysis of the industry on the basis of market segments, market dynamics, market size, competition & companies involved value chain • Global Animal Antibiotics and Antimicrobials Market analysis and comprehensive segmentation with respect to the product, mode of delivery, type of animal, and geography to assist in strategic business planning • Global Animal Antibiotics and Antimicrobials Market analysis and forecast for five major geographies North America, Europe, Asia pacific, Middle East & Africa, Latin America and their key regions. Research Methodology: Research methodology used in this report contains various secondary sources including Bloomberg, Hoovers, and Factiva. Experts from top manufacturing companies along with other stakeholders have been considered. This is done to validate and collect critical information for evaluating trends related to this market during the forecast period. Top-down and bottom-up approaches have been used to estimate the global and regional size of this market. Data triangulation techniques along with other comparative analysis are also used to calculate the exact size of the Global Animal Antibiotics and Antimicrobials Market globally. Key Players in the Global Animal Antibiotics and Antimicrobials Market Are: • Bioniche Animal Health • Elanco Animal Health • Fort Dodge Animal Health • Dechra Pharmaceuticals PLC • Vetoquinol S.A. • Virbac • Ceva Sante Animale • Sanofi • Bayer AG • Merck & Co., Inc. • Eli Lilly and Company • Boehringer Ingelheim GmbH • Zoetis, Inc. Key Target Audience: • Research and Consulting Firms as well as Venture capitalists, private equity firms, and startup companies • Animal Pharmaceutical Manufacturers • Animal Health Research and Development (R&D) Companies • Animal Healthcare Product Distributors • Contract research organizations (CROs) • Government Bodies Scope of the Report: Research report categorizes the Global Animal Antibiotics and Antimicrobials Market based on product, mode of delivery, type of animal, and geography (region wise). Market size by value is estimated and forecasted with the revenues of leading companies operating in the Global Animal Antibiotics and Antimicrobials Market with key developments in companies and market trends. Global Animal Antibiotics and Antimicrobials Market, By Product: • Tetracyclines • Penicillins • Sulfonamides • Macrolides • Aminoglycosides • Lincosamides • Fluoroquinolones • Cephalosporins • Other Antimicrobials and Antibiotics Global Animal Antibiotics and Antimicrobials Market, By Mode of Delivery: • Premixes • Oral Powders • Oral Solutions • Injections • Other Modes of Delivery Global Animal Antibiotics and Antimicrobials Market, By Type of Animal: • Food-Producing Animals • Companion Animals Global Animal Antibiotics and Antimicrobials Market, By Geography: • North America • Europe • Asia Pacific • Middle East & Africa • Latin America Available Customization: Maximize Market Research offers customization of report and scope of the report as per the specific requirement of our client.   Global Parkinson’s Disease Treatment Market - Industry Analysis and Forecast 2024

Table of Contents

1. EXECUTIVE SUMMARY 2. RESEARCH METHODOLOGY 2.1. Market Definition 2.2. Market Scope 2.3. Data Sources 3. MARKET DYNAMICS 3.1. Market Drivers 3.2. Market Restraints 3.3. Market Opportunities 4. END-USER OVERVIEW 4.1. Value Chain Analysis 4.2. Key Trends 5. GLOBAL ANIMAL ANTIBIOTICS AND ANTIMICROBIALS MARKET, BY PRODUCT (2017-2024) 5.1. Introduction 5.2. Tetracyclines 5.2.1. Tetracyclines Market Overview 5.2.2. Tetracyclines Market Size & Forecast 5.3. Penicillins 5.3.1. Penicillins Market Overview 5.3.2. Penicillins Market Size & Forecast 5.4. Sulfonamides 5.4.1. Sulfonamides Market Overview 5.4.2. Sulfonamides Market Size & Forecast 5.5. Macrolides 5.5.1. Macrolides Market Overview 5.5.2. Macrolides Market Size & Forecast 5.6. Aminoglycosides 5.6.1. Aminoglycosides Market Overview 5.6.2. Aminoglycosides Market Size & Forecast 5.7. Lincosamides 5.7.1. Lincosamides Market Overview 5.7.2. Lincosamides Market Size & Forecast 5.8. Fluoroquinolones 5.8.1. Fluoroquinolones Market Overview 5.8.2. Fluoroquinolones Market Size & Forecast 5.9. Cephalosporins 5.9.1. Cephalosporins Market Overview 5.9.2. Cephalosporins Market Size & Forecast 5.10. Other Antimicrobials and Antibiotics 5.10.1. Other Antimicrobials and Antibiotics Market Overview 5.10.2. Other Antimicrobials and Antibiotics Market Size & Forecast 6. GLOBAL ANIMAL ANTIBIOTICS AND ANTIMICROBIALS MARKET, BY MODE OF DELIVERY (2017-2024) 6.1. Introduction 6.2. Premixes 6.2.1. Premixes Market Overview 6.2.2. Premixes Market Size & Forecast 6.3. Oral Powders 6.3.1. Oral Powders Market Overview 6.3.2. Oral Powders Market Size & Forecast 6.4. Oral Solutions 6.4.1. Oral Solutions Market Overview 6.4.2. Oral Solutions Market Size & Forecast 6.5. Injections 6.5.1. Injections Market Overview 6.5.2. Injections Market Size & Forecast 6.6. Other Modes of Delivery 6.6.1. Other Modes of Delivery Market Overview 6.6.2. Other Modes of Delivery Market Size & Forecast 7. GLOBAL ANIMAL ANTIBIOTICS AND ANTIMICROBIALS MARKET, BY TYPE OF ANIMAL (2017-2024) 7.1. Introduction 7.2. Food-Producing Animals 7.2.1. Food-Producing Animals Market Overview 7.2.2. P Food-Producing Animals remixes Market Size & Forecast 7.3. Companion Animals 7.3.1. Companion Animals Market Overview 7.3.2. Companion Animals Market Size & Forecast 8. GLOBAL ANIMAL ANTIBIOTICS AND ANTIMICROBIALS MARKET, BY GEOGRAPHY (2017-2024) 8.1. North America Animal Antibiotics and Antimicrobials Market 8.1.1. North America Animal Antibiotics and Antimicrobials Market, By Mode of Delivery 8.1.2. North America Animal Antibiotics and Antimicrobials Market, By Type of Animal 8.1.3. North America Animal Antibiotics and Antimicrobials Market, By Product 8.1.4. North America Animal Antibiotics and Antimicrobials Market, by Region 8.1.4.1. U.S. Animal Antibiotics and Antimicrobials Market 8.1.4.2. Canada Animal Antibiotics and Antimicrobials Market 8.1.4.3. Mexico Animal Antibiotics and Antimicrobials Market 8.2. Europe Animal Antibiotics and Antimicrobials Market 8.2.1. Europe Animal Antibiotics and Antimicrobials Market, By Mode of Delivery 8.2.2. Europe Animal Antibiotics and Antimicrobials Market, By Type of Animal 8.2.3. Europe Animal Antibiotics and Antimicrobials Market, By Product 8.2.4. Europe Global Animal Antibiotics and Antimicrobials Market, by Region 8.2.4.1. France Animal Antibiotics and Antimicrobials Market 8.2.4.2. Germany Animal Antibiotics and Antimicrobials Market 8.2.4.3. U.K. Animal Antibiotics and Antimicrobials Market 8.2.4.4. Italy Animal Antibiotics and Antimicrobials Market 8.2.4.5. Spain Animal Antibiotics and Antimicrobials Market 8.2.4.6. Rest of Europe Animal Antibiotics and Antimicrobials Market 8.3. Asia Pacific Animal Antibiotics and Antimicrobials Market 8.3.1. Asia-Pacific Animal Antibiotics and Antimicrobials Market, By Mode of Delivery 8.3.2. Asia-Pacific Animal Antibiotics and Antimicrobials Market, By Type of Animal 8.3.3. Asia-Pacific Animal Antibiotics and Antimicrobials Market, By Product 8.3.4. Asia-Pacific Animal Antibiotics and Antimicrobials Market, by Region 8.3.4.1. China Animal Antibiotics and Antimicrobials Market 8.3.4.2. Japan Animal Antibiotics and Antimicrobials Market 8.3.4.3. India Animal Antibiotics and Antimicrobials Market 8.3.4.4. South Korea Animal Antibiotics and Antimicrobials Market 8.3.4.5. Rest of Asia Pacific Animal Antibiotics and Antimicrobials Market 8.4. Middle East & Africa Animal Antibiotics and Antimicrobials Market 8.4.1. Middle East & Africa Animal Antibiotics and Antimicrobials Market, By Mode of Delivery 8.4.2. Middle East & Africa Animal Antibiotics and Antimicrobials Market, By Type of Animal 8.4.3. Middle East & Africa Animal Antibiotics and Antimicrobials Market, By Product 8.4.4. Middle East & Africa Animal Antibiotics and Antimicrobials Market, by Region 8.4.4.1. South Africa Animal Antibiotics and Antimicrobials Market 8.4.4.2. Rest of Middle East and Africa Animal Antibiotics and Antimicrobials Market 8.5. Latin America Animal Antibiotics and Antimicrobials Market 8.5.1. Latin America Animal Antibiotics and Antimicrobials Market, By Mode of Delivery 8.5.2. Latin America Animal Antibiotics and Antimicrobials Market, By Type of Animal 8.5.3. Latin America Animal Antibiotics and Antimicrobials Market, By Product 8.5.4. Latin America Animal Antibiotics and Antimicrobials Market, by Region 8.5.4.1. Brazil Animal Antibiotics and Antimicrobials Market 8.5.4.2. Rest of Latin America Animal Antibiotics and Antimicrobials Market 9. MARKET COMPETITION ANALYSIS 9.1 Market Share/Positioning Analysis 9.2 Key Innovators 9.3 Company Profiles 9.3.1 Bioniche Animal Health 9.3.1.1 Overview 9.3.1.2 Products/ End-User 9.3.1.3 Strategy 9.3.1.4 Key Developments 9.3.2 Elanco Animal Health 9.3.2.1 Overview 9.3.2.2 Products/ End-User 9.3.2.3 Strategy 9.3.2.4 Key Developments 9.3.3 Fort Dodge Animal Health 9.3.3.1 Overview 9.3.3.2 Products/ End-User 9.3.3.3 Strategy 9.3.3.4 Key Developments 9.3.4 Dechra Pharmaceuticals PLC 9.3.4.1 Overview 9.3.4.2 Products/ End-User 9.3.4.3 Strategy 9.3.4.4 Key Developments 9.3.5 Vetoquinol S.A. 9.3.5.1 Overview 9.3.5.2 Products/ End-User 9.3.5.3 Strategy 9.3.5.4 Key Developments 9.3.6 Virbac 9.3.6.1 Overview 9.3.6.2 Products/ End-User 9.3.6.3 Strategy 9.3.6.4 Key Development 9.3.7 Ceva Sante Animale 9.3.7.1 Overview 9.3.7.2 Products/ End-User 9.3.7.3 Strategy 9.3.7.4 Key Development 9.3.8 Sanofi 9.3.8.1 Overview 9.3.8.2 Products/ End-User 9.3.8.3 Strategy 9.3.8.4 Key Development 9.3.9 Bayer AG 9.3.9.1 Overview 9.3.9.2 Products/ End-User 9.3.9.3 Strategy 9.3.9.4 Key Development 9.3.10 Merck & Co., Inc. 9.3.10.1 Overview 9.3.10.2 Products/ End-User 9.3.10.3 Strategy 9.3.10.4 Key Development 9.3.11 Eli Lilly and Company 9.3.11.1 Overview 9.3.11.2 Products/ End-User 9.3.11.3 Strategy 9.3.11.4 Key Development 9.3.12 Boehringer Ingelheim GmbH 9.3.12.1 Overview 9.3.12.2 Products/ End-User 9.3.12.3 Strategy 9.3.12.4 Key Development 9.3.13 Zoetis, Inc. 9.3.13.1 Overview 9.3.13.2 Products/ End-User 9.3.13.3 Strategy 9.3.13.4 Key Development

Inquiry Before Buying

Request Sample

About This Report

Report ID6857
Category Healthcare
Publisher Name
No of Pages
Total Views
Published Date
Contact Us
Call Now